Learn how to improve contract manufacturing operations from Mr Jason Li, Director, Downstream Processing, Genor Biopharma, China, at Biologic Manufacturing World Asia 2012, part of a series of conferences in the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore.
Mr Li has over 15 years of experience in the Biotechnology Industry and more than 10 years of that was spent on the Development and manufacturing of biopharmaceuticals in U.S., such as Global Process Engineering in Amgen and Process Development in Invitrogen. The products he has worked on include blockbuster drugs Epogen and Neupogen, as well as monoclonal antibodies for Oncology, gene therapy vectors, etc. He majored in Biochemical Engineering, with Masters of Engineering from Tianjin University and Masters of Science from University of Maryland. Currently, his main responsibilities in Genor Biopharma cover many aspects of product commercialization, including downstream process development, process validation, technology transfer and new facility. His recent presentations include topics on process analytical technology (PAT) in chromatography and monoclonal antibodies.
Mr Li will be presenting on the following topics:
1. Leveraging on Asia's advantage of lower costs and newer facilities for single-use systems in contract manufacturing operations
2. Effectively tapping on the benefits of single-use systems in contract manufacturing of clinical materials
3. Case study: Tapping on disposable systems in commercial manufacturing facility design to lower cost